YFM exits Cozart

YFM Private Equity has made a 4x return on the sale of Cozart, an AIM-listed medical diagnostics company, to Concateno for £64.4m.

1 December 2007•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail